MACSima instrument

1.1.

Køber

Officielt navn : Københavns Universitet

E-mail : bettina.dion@adm.ku.dk

Køberens retlige status : Offentligretligt organ

Den ordregivende myndigheds aktivitet : Uddannelse

2.1.

Procedure

Titel : MACSima instrument

Beskrivelse : BRIC has chosen to accept the offer from Miltenyi Biotec] as, we believe that only the MACSIMA platform from Miltenyi Biotec is addressing our needs sufficiently. We need a multiplex staining platform with minimal tissue damage afflicted during each cycle and an efficient software to stitch the partial images, to subtract background lfuorescence, and to analyze the complete images. Only the MACSIMA platform showed that it can stain more than 400 markers without detectable loss of quality, which is unmatched by other products. Furthermore, the iQView software used for running the platform as well as for analyzing the images is both robust as well as powerful, and to our mind better than those of potential alternative products. Therefore we are not interested in acquiring any other multiplex immunofluorescent staining platform currently available on the market. The reason for the purchase is to allow us immediate access to this breakthrough technology.

Identifikator for proceduren : 71f8c1f5-24d2-4d72-89f0-978cb7c0684f

Intern ID : 043-1363/24-7000

Udbudsprocedure : Udbud med forhandling uden forudgående offentliggørelse

2.1.1.

Formål

Kontraktens hovedformål : Varer

Primær klassifikation ( cpv ): 38000000 Laboratorieudstyr, optisk udstyr og præcisionsudstyr (ikke briller)

2.1.2.

Udførelsessted

Landsdel (NUTS) : Byen København ( DK011 )

Land : Danmark

2.1.4.

Generelle oplysninger

Retsgrundlag :

Direktiv 2014/24/EU

5.1.

Delkontrakt : LOT-0000

Titel : MACSima instrument

Beskrivelse : BRIC has chosen to accept the offer from Miltenyi Biotec] as, we believe that only the MACSIMA platform from Miltenyi Biotec is addressing our needs sufficiently. We need a multiplex staining platform with minimal tissue damage afflicted during each cycle and an efficient software to stitch the partial images, to subtract background lfuorescence, and to analyze the complete images. Only the MACSIMA platform showed that it can stain more than 400 markers without detectable loss of quality, which is unmatched by other products. Furthermore, the iQView software used for running the platform as well as for analyzing the images is both robust as well as powerful, and to our mind better than those of potential alternative products. Therefore we are not interested in acquiring any other multiplex immunofluorescent staining platform currently available on the market. The reason for the purchase is to allow us immediate access to this breakthrough technology.

Intern ID : 1

5.1.1.

Formål

Kontraktens hovedformål : Varer

Primær klassifikation ( cpv ): 38000000 Laboratorieudstyr, optisk udstyr og præcisionsudstyr (ikke briller)

Mængde : 1

5.1.2.

Udførelsessted

Landsdel (NUTS) : Byen København ( DK011 )

Land : Danmark

5.1.6.

Generelle oplysninger

Indkøbsprojekt, der ikke finansieres med EU-midler

Udbuddet er omfattet af aftalen om offentlige udbud (GPA) : ja

5.1.10.

Tildelingskriterier

Kriterium :

Type : Kvalitet

Navn : Forskningsresultater

Beskrivelse : BRIC has chosen to accept the offer from Miltenyi Biotec] as, we believe that only the MACSIMA platform from Miltenyi Biotec is addressing our needs sufficiently. We need a multiplex staining platform with minimal tissue damage afflicted during each cycle and an efficient software to stitch the partial images, to subtract background lfuorescence, and to analyze the complete images. Only the MACSIMA platform showed that it can stain more than 400 markers without detectable loss of quality, which is unmatched by other products. Furthermore, the iQView software used for running the platform as well as for analyzing the images is both robust as well as powerful, and to our mind better than those of potential alternative products. Therefore we are not interested in acquiring any other multiplex immunofluorescent staining platform currently available on the market. The reason for the purchase is to allow us immediate access to this breakthrough technology.

5.1.15.

Teknikker

Rammeaftale : Ingen rammeaftale

Oplysninger om det dynamiske indkøbssystem : Intet dynamisk indkøbssystem

5.1.16.

Yderligere oplysninger, mægling og gennemgang

Organisation med ansvar for klager : Klagenævnet for Udbud

Organisation, der leverer yderligere oplysninger om klageprocedurerne : Konkurrence- og Forbrugerstyrelsen

TED eSender : Mercell Holding ASA

Værdien af alle kontrakter tildelt i denne bekendtgørelse : 1 826 147,00 DKK

Direkte tildeling :

Begrundelse for direkte tildeling : Kontrakten kan kun tildeles af en bestemt økonomisk aktør på grund af manglende konkurrence af tekniske årsager

Anden begrundelse : BRIC has chosen to accept the offer from Miltenyi Biotec] as, we believe that only the MACSIMA platform from Miltenyi Biotec is addressing our needs sufficiently. We need a multiplex staining platform with minimal tissue damage afflicted during each cycle and an efficient software to stitch the partial images, to subtract background lfuorescence, and to analyze the complete images. Only the MACSIMA platform showed that it can stain more than 400 markers without detectable loss of quality, which is unmatched by other products. Furthermore, the iQView software used for running the platform as well as for analyzing the images is both robust as well as powerful, and to our mind better than those of potential alternative products. Therefore we are not interested in acquiring any other multiplex immunofluorescent staining platform currently available on the market. The reason for the purchase is to allow us immediate access to this breakthrough technology.

6.1.

Resultat delkontrakt-ID : LOT-0000

6.1.2.

Oplysninger om vinderne

Vinder :

Officielt navn : Miltenyi Biotec Norden AB

Tilbud :

Tilbud – Identifikator : Miltenyi Quotation 7042064-01

ID for delkontrakt eller gruppe af delkontrakter : LOT-0000

Kontraktoplysninger:

Identifikator for kontrakten : 043-1363/24-7000

Datoen for udvælgelsen af det vindende tilbud : 13/11/2024

8.1.

ORG-0001

Officielt navn : Københavns Universitet

Registreringsnummer : 29979812

Postadresse : Nørregade 10

By : København K

Postnummer : 1165

Landsdel (NUTS) : Byen København ( DK011 )

Land : Danmark

Enhed : Bettina Petersen

E-mail : bettina.dion@adm.ku.dk

Telefon : +45 35327223

Internetadresse : http://www.ku.dk/

Køberprofil : https://eu.eu-supply.com/ctm/company/companyinformation/index/166597

Denne organisations roller :

Køber

8.1.

ORG-0002

Officielt navn : Klagenævnet for Udbud

Registreringsnummer : 37795526

Postadresse : Nævnenes Hus, Toldboden 2

By : Viborg

Postnummer : 8800

Landsdel (NUTS) : Vestjylland ( DK041 )

Land : Danmark

E-mail : klfu@naevneneshus.dk

Telefon : +45 72405600

Internetadresse : https://naevneneshus.dk/start-din-klage/klagenaevnet-for-udbud/

Denne organisations roller :

Organisation med ansvar for klager

8.1.

ORG-0003

Officielt navn : Konkurrence- og Forbrugerstyrelsen

Registreringsnummer : 10294819

Postadresse : Carl Jacobsens vej 35

By : Valby

Postnummer : 2500

Landsdel (NUTS) : Byen København ( DK011 )

Land : Danmark

E-mail : kfst@kfst.dk

Telefon : +45 41715000

Internetadresse : https://www.kfst.dk

Denne organisations roller :

Organisation, der leverer yderligere oplysninger om klageprocedurerne

8.1.

ORG-0004

Officielt navn : Miltenyi Biotec Norden AB

Registreringsnummer : 556873-8545

Postadresse : Scheeletorget 1

By : Lund

Postnummer : 223 81

Landsdel (NUTS) : Skåne län ( SE224 )

Land : Sverige

E-mail : macsse@miltenyi.com

Telefon : 00430200111800

Denne organisations roller :

Tilbudsgiver

Vinder af disse delkontrakter : LOT-0000

Vinderen er noteret på et reguleret marked

8.1.

ORG-0005

Officielt navn : Mercell Holding ASA

Registreringsnummer : 980921565

Postadresse : Askekroken 11

By : Oslo

Postnummer : 0277

Landsdel (NUTS) : Oslo ( NO081 )

Land : Norge

Enhed : eSender

E-mail : publication@mercell.com

Telefon : +47 21018800

Fax : +47 21018801

Internetadresse : http://mercell.com/

Denne organisations roller :

TED eSender

11.1.

Oplysninger om bekendtgørelsen

Bekendtgørelsens ID : 6b250f18-501a-4a96-84c1-ee755bc5b783 - 01

Formulartype : Forudgående underretning om direkte tildeling

Bekendtgørelsestype : Bekendtgørelse med henblik på frivillig forudgående gennemsigtighed

Bekendtgørelsesundertype : 25

Afsendelsesdato for bekendtgørelsen : 13/11/2024 10:50:23 (UTC)

Dato for afsendelse af bekendtgørelsen (eSender) : 13/11/2024 13:30:33 (UTC)

Bekendtgørelsens officielle sprog : dansk

11.2.

Oplysninger om offentliggørelsen

Bekendtgørelsesnummer : 694348-2024

EUT-S-nummer : 222/2024

Offentliggørelsesdato : 14/11/2024

{{ visitor.person.name }}

Fakta om udbudet

MACSima instrument

Københavns Universitet

Send til en kollega